Brief: Abbisko Cayman Says CSF-1R Inhibitor Pimicotinib Granted Fast Track Designation By U.S. FDA
Dec 14 (Reuters) - Abbisko Cayman Ltd 2256.HK :
* CSF-1R INHIBITOR PIMICOTINIB (ABSK021) GRANTED FAST TRACK
DESIGNATION BY U.S. FDA
Further company coverage: 2256.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Abbisko Cayman
See all newsHK-listed Abbisko climbs most in 12 weeks on Eli Lilly tie-up
Abbisko Therapeutics enters potential $1.9 billion R&D deal with Eli Lilly (updated)
Brief: Abbisko Therapeutics Deepens R+D- Collaboration With Lilly
Abbisko Therapeutics enters potential $1.9 billion R&D deal with Eli Lilly
Brief: Abbisko Therapeutics Enters Strategic Research Collaboration And License Agreement With Eli Lilly